These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10069171)

  • 41. The endometrial nucleolar channel system as an indicator of progestin potency in HRT.
    Ryder TA; Mobberley MA; Whitehead MI
    Maturitas; 1995 Jun; 22(1):31-6. PubMed ID: 7666814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Proliferation of the endometrium and vaginal epithelium through conjugated estrogens].
    Heinen G; Siegel P
    Zentralbl Gynakol; 1967 Jun; 89(23):826-31. PubMed ID: 4296589
    [No Abstract]   [Full Text] [Related]  

  • 43. Endometrial cytology in postmenopausal hormone replacement therapy.
    Kaba S; Aoki T; Fukatsu T
    Diagn Cytopathol; 1998 Sep; 19(3):161-7. PubMed ID: 9740987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [III. Effect of conjugated estrogens on the endometrium].
    Dabancens A; Fuensalida S; González O
    Rev Chil Obstet Ginecol; 1976; 41(6):341-4. PubMed ID: 208113
    [No Abstract]   [Full Text] [Related]  

  • 45. [Estrogen treatment of women after the menopause].
    Furuhjelm M
    Lakartidningen; 1974 Feb; 71(7):605-7. PubMed ID: 4365587
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of progesterone administered by nasal spray on the human postmenopausal endometrium.
    Cicinelli E; Petruzzi D; Scorcia P; Resta L
    Maturitas; 1993 Dec; 18(1):65-72. PubMed ID: 8107618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioidentical hormones: what is all the hype about?
    Panay N; Fenton A
    Climacteric; 2010 Feb; 13(1):1-3. PubMed ID: 20067429
    [No Abstract]   [Full Text] [Related]  

  • 48. Estrogen replacement therapy and endometrial hyperplasia.
    Subbiah MT
    JAMA; 1996 Jun; 275(24):1880-1. PubMed ID: 8648860
    [No Abstract]   [Full Text] [Related]  

  • 49. The endometrial and breast safety of menopausal hormone therapy containing micronised progesterone: A short review.
    Eden J
    Aust N Z J Obstet Gynaecol; 2017 Feb; 57(1):12-15. PubMed ID: 28251642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphologic and morphometric aspects of the endometrium of postmenopausal women before and after cyclic oestrogen replacement treatment.
    Gomes AM; Baracat EC; Simões MJ; Haidar MA; Focchi GR; Evêncio-Neto J; de Lima GR
    Eur J Obstet Gynecol Reprod Biol; 1997 Jul; 74(1):79-82. PubMed ID: 9243208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endometrial response to different estrogens.
    Myhre E
    Front Horm Res; 1977; 5():126-44. PubMed ID: 208879
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of progesterone injection on progesterone receptor levels and distribution in untreated and short-term Premarin-primed pre-menopausal and post-menopausal endometrium.
    Gorodeski IG; Geier A; Lunenfeld B; Sigal A; Beery R; Serr D; Bahary CM
    Maturitas; 1986 Dec; 8(4):353-8. PubMed ID: 3033446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Proliferation dosage and threshold dosage of conjugated estrogens].
    Kraus H; Heinen G; Mootz M
    Geburtshilfe Frauenheilkd; 1971 Jul; 31(7):669-77. PubMed ID: 4327502
    [No Abstract]   [Full Text] [Related]  

  • 54. An alternative regimen of hormone replacement therapy to improve patient compliance.
    Kemp JF; Fryer JA; Baber RJ
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):66-9. PubMed ID: 2562774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormone replacement therapy with conjugated estrogens and high blood pressure: response to Dr. Jespersen.
    Wong PS; Lip GY; Beevers DG
    Am J Hypertens; 1997 May; 10(5 Pt 1):579. PubMed ID: 9160772
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of the nuclear progesterone receptor in normal Premarin-primed post-menopausal endometrium.
    Gorodeski IG; Geier A; Beery R; Lunenfeld B; Serr D; Bahary CM
    Maturitas; 1986 Dec; 8(4):345-52. PubMed ID: 3033445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Administration of estrogens in otosclerosis].
    Zenner HP; Weber B
    HNO; 1994 Jun; 42(6):374. PubMed ID: 8071099
    [No Abstract]   [Full Text] [Related]  

  • 58. Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.
    Epplein M; Reed SD; Voigt LF; Newton KM; Holt VL; Weiss NS
    Ann Epidemiol; 2009 Jan; 19(1):1-7. PubMed ID: 19064186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endometrial patterns observed in estrogen-progesterone combination therapy.
    Anthikad I; Reys M; Sikand S
    Indian J Pathol Bacteriol; 1974 Oct; 17(4):221-5. PubMed ID: 4457476
    [No Abstract]   [Full Text] [Related]  

  • 60. Micronised transdermal progesterone and endometrial response.
    Wren BG; McFarland K; Edwards L
    Lancet; 1999 Oct; 354(9188):1447-8. PubMed ID: 10543679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.